Skip to content
  • Saturday, 15 August 2026
  • 3:06 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • New Yale Study Challenges Traditional Views of Inevitable Decline by Revealing Significant Physical and Cognitive Gains in Older Adults
Neuroscience & Brain Research

New Yale Study Challenges Traditional Views of Inevitable Decline by Revealing Significant Physical and Cognitive Gains in Older Adults

Rifan Muazin Jul 8, 2026 0

The long-held scientific and societal assumption that aging is a process of strictly linear decline is being fundamentally challenged by…

Read More
Neuroscience & Brain Research

Yale University Research Reveals Significant Cognitive and Physical Gains Among Older Adults Challenging Conventional Views on Aging

Rifan Muazin Jun 21, 2026 0

For decades, the prevailing scientific and social narrative surrounding the aging process has been one of inevitable decline, characterized by…

Read More
Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major DepressionMerck & Co. Acquires Terns Pharmaceuticals, Bolstering Chronic Myeloid Leukemia Pipeline with FDA Breakthrough Designation for TERN-701Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Dismantling Differentiation BarriersPharma Manufacturing Facility Sales to Outsourcers Signal Growing Industry Demand for Strategic Flexibility
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ